Cargando…

Study on preventing adverse events in neonates (SEPREVEN): A stepped-wedge randomised controlled trial to reduce adverse event rates in the NICU

INTRODUCTION: Adverse events (AE) in care are recognized as a leading cause of mortality and injury in patients. Improving patients’ safety is difficult to achieve. Therefore, innovative research strategies are needed to identify errors in subgroups of patients and related severity of outcomes as we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caeymaex, Laurence, Lebeaux, Cecile, Roze, Jean Christophe, Danan, Claude, Reynaud, Audrey, Jung, Camille, Audureau, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	6200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402760/ https://www.ncbi.nlm.nih.gov/pubmed/32756081 http://dx.doi.org/10.1097/MD.0000000000020912

Ejemplares similares

Assessment of the risk of musculoskeletal adverse events associated with fluoroquinolone use in children: A meta-analysis
por: Wang, Ji-gan, et al.
Publicado: (2020)

Determinants of morbidity and mortality related to health care-associated primary bloodstream infections in neonatal intensive care units: a prospective cohort study from the SEPREVEN trial
por: Jaloustre, Morgane, et al.
Publicado: (2023)

Effects of combined oral sucrose and nonnutritive sucking (NNS) on procedural pain of NICU newborns, 2001 to 2016: A PRISMA-compliant systematic review and meta-analysis
por: Liu, Yi, et al.
Publicado: (2017)

Reduced maternal calcium intake through nutrition and supplementation is associated with adverse conditions for both the women and their infants in a Chinese population
por: Liu, Xiaohong, et al.
Publicado: (2017)

Living with a Crucial Decision: A Qualitative Study of Parental Narratives Three Years after the Loss of Their Newborn in the NICU
por: Caeymaex, Laurence, et al.
Publicado: (2011)

Genome-wide analysis of RNA-binding protein co-expression with alternative splicing events in acute respiratory distress syndrome following hematopoietic stem cell transplantation
por: Luo, Jinghua, et al.
Publicado: (2023)

Quality of life and Q-TWiST were not adversely affected in Ewing sarcoma patients treated with combined anlotinib, irinotecan, and vincristine: (Peking University People's Hospital Ewing sarcoma trial-02, PKUPH-EWS-02)
por: Dong, Sen, et al.
Publicado: (2021)

Improving patient self-reporting of antihypertensive adverse drug events in primary care: a stepped wedge cluster randomised trial
por: Buchet-Poyau, Karine, et al.
Publicado: (2021)

Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trial
por: Keriel-Gascou, Maud, et al.
Publicado: (2013)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
por: Negishi, Akio, et al.
Publicado: (2020)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
por: Budikayanti, Astri, et al.
Publicado: (2018)

Adverse events of targeted therapies approved for women's cancers
por: Saint-Ghislain, Mathilde, et al.
Publicado: (2021)

OAE: The Ontology of Adverse Events
por: He, Yongqun, et al.
Publicado: (2014)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Biomedicines as Adverse Event Inducers
por: Tridente, Giuseppe
Publicado: (2013)

Litigations for Unexpected Adverse Events
por: Fong, I. W.
Publicado: (2010)

Fluoroquinolone antibiotics and adverse events
por: Baggio, Diva, et al.
Publicado: (2021)

Adverse Events in NMOSD Therapy
por: Giglhuber, Katrin, et al.
Publicado: (2022)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

Adverse Events of DOACs in Children
por: Bosch, Alessandra, et al.
Publicado: (2022)

Adverse Events Related to Tirzepatide
por: Mishra, Rahul, et al.
Publicado: (2023)

Evaluating adverse events in databases
por: Lovell, Katie, et al.
Publicado: (2023)

Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management
Publicado: (2019)

Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
por: Roitmann, Eva, et al.
Publicado: (2014)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
por: Lao, Dong-Hui, et al.
Publicado: (2021)

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events
por: Hehir, Michael K., et al.
Publicado: (2022)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
por: Yamashiro, Kaito, et al.
Publicado: (2022)

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
por: Noda, Aoi, et al.
Publicado: (2020)

Topiramate-related adverse events: Pattern and signals in the Korea Adverse Event Reporting System, 2010-2017
por: Choi, Junyeong, et al.
Publicado: (2020)

Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
por: Mizuno, Takahito, et al.
Publicado: (2021)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
por: Kim, Tae-Hun, et al.
Publicado: (2023)

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
por: Zou, Shu-peng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3lpujru8geon740aasd7gor6t9